| Nathan Renley, MS, CCC-SLP | |
|
2925 Virginia Dale Dr, Fort Collins, CO 80521-4034 | |
| (505) 787-4864 | |
| Not Available |
| Full Name | Nathan Renley |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 2925 Virginia Dale Dr, Fort Collins, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134665706 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP.0003257 (Colorado) | Primary |
| Provider Name | Covell Care And Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063695351 PECOS PAC ID: 9335223429 Enrollment ID: O20080228000078 |
News Archive
Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration, is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.
The wing of a fruit fly may hold the key to unraveling the genetic and molecular events that transform a normal cell into a cancerous one. The study, conducted on Drosophila melanogaster by scientists at the Institute for Research in Biomedicine (IRB Barcelona) and led by ICREA researcher Marco Mil-n, has reproduced each of the steps known to take place when a healthy cell turns cancerous.
Microfluidic Systems, a privately-held company, announced today that they received an award from Inc. Magazine. The Fourth Annual Exclusive List of America's Fastest-Growing Private Companies—the Inc. 5000 ranked Microfluidic Systems number 3035 with a growth rate of 68%. The list represents the most comprehensive look at the most important segment of the economy—America's independent-minded entrepreneurs.
Erbitux (cetuximab), offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an article written by two Mayo Clinic cancer researchers published in the current edition of the New England Journal of Medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan Renley, MS, CCC-SLP 2925 Virginia Dale Dr, Fort Collins, CO 80521-4034 Ph: (505) 787-4864 | Nathan Renley, MS, CCC-SLP 2925 Virginia Dale Dr, Fort Collins, CO 80521-4034 Ph: (505) 787-4864 |
News Archive
Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration, is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.
The wing of a fruit fly may hold the key to unraveling the genetic and molecular events that transform a normal cell into a cancerous one. The study, conducted on Drosophila melanogaster by scientists at the Institute for Research in Biomedicine (IRB Barcelona) and led by ICREA researcher Marco Mil-n, has reproduced each of the steps known to take place when a healthy cell turns cancerous.
Microfluidic Systems, a privately-held company, announced today that they received an award from Inc. Magazine. The Fourth Annual Exclusive List of America's Fastest-Growing Private Companies—the Inc. 5000 ranked Microfluidic Systems number 3035 with a growth rate of 68%. The list represents the most comprehensive look at the most important segment of the economy—America's independent-minded entrepreneurs.
Erbitux (cetuximab), offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an article written by two Mayo Clinic cancer researchers published in the current edition of the New England Journal of Medicine.
› Verified 3 days ago
Kristin Preuss Martinez, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1736 Concord Dr, Fort Collins, CO 80526 Phone: 970-817-0902 | |
Jessica Rose Mcguire, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2407 Laporte Ave, Fort Collins, CO 80521 Phone: 847-507-7674 | |
Bradshaw Voice And Speech Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1918 S Lemay Ave Ste A, Fort Collins, CO 80525 Phone: 435-640-6603 | |
Ms. Krista Kathryn Lancia, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3509 Lochwood Dr, Fort Collins, CO 80525 Phone: 970-432-8810 | |
Morrine Mary Moody, CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Stuart St, Fort Collins, CO 80525 Phone: 970-482-5712 | |
Summit Speech Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1730 S College Ave Ste 301, Fort Collins, CO 80525 Phone: 970-900-6930 Fax: 970-449-0576 | |
Mrs. Susan Elizabeth Fischer, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3050 Barn Swallow Circle, Fort Collins, CO 80524 Phone: 970-407-1995 |